XML 72 R59.htm IDEA: XBRL DOCUMENT v3.23.2
Reportable Segments - Schedule of Adjusted EBITDA Reconciled to Net Income (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Segment Reporting Information [Line Items]            
Interest expense, net $ 3,887   $ 3,112   $ 12,568 $ 2,262
Provision for income taxes 3,968   5,432   4,649 10,367
Depreciation and amortization 32,056   34,407   63,922 68,441
Shares based compensation 3,601   1,943   5,659 3,802
Net income 9,782 $ 1,925 14,236 $ 13,013 11,707 27,249
Segments            
Segment Reporting Information [Line Items]            
Total Adjusted EBITDA 55,971   60,834   104,531 114,434
Interest expense, net 3,887   3,112   12,568 2,262
Provision for income taxes 3,968   5,432   4,649 10,367
Depreciation and amortization 32,056   34,407   63,922 68,441
Shares based compensation 3,601   1,943   5,659 3,802
Transaction and acquisition-related charges [1] 1,190   1,179   2,261 2,677
Integration, restructuring, and other charges [2] 1,487   525   3,765 (364)
Net income 9,782   14,236   11,707 27,249
Segments | Americas            
Segment Reporting Information [Line Items]            
Total Adjusted EBITDA 52,324   52,954   96,980 99,773
Segments | International            
Segment Reporting Information [Line Items]            
Total Adjusted EBITDA $ 3,647   $ 7,880   $ 7,551 $ 14,661
[1] Represents charges incurred related to acquisitions and similar transactions, primarily consisting of change in control-related costs, professional service fees, and other third-party costs. Additionally includes incremental professional service fees incurred related to the initial public offering and subsequent one-time compliance efforts. The three and six months ended June 30, 2023 and 2022 include a transaction bonus expense related to one of the Company’s 2021 acquisitions.
[2] Represents charges from organizational restructuring and integration activities, non-cash, and other charges primarily related to nonrecurring legal exposures, foreign currency (gains) losses, and (gains) losses on the sale of assets.